CNS Pharmaceuticals Inc (CNSP)
0.111
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
0.1124
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals Market Cap: 6.381M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Ligand Pharmaceuticals Inc | 2.165B |
Cellectar Biosciences Inc | 9.698M |
Revance Therapeutics Inc | 323.10M |
Zymeworks Inc | 973.93M |
NovaBay Pharmaceuticals Inc | 2.589M |
Market Cap Related Metrics
Price to Book Value | 1.904 |
Price | 0.111 |
Earnings Yield | -63.71K% |